Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,000 | -30,074 | -22,080 | -14,237 | -12,429 |
| Depreciation Amortization | N/A | 879 | 631 | 534 | 264 |
| Accounts payable and accrued liabilities | 240 | -468 | -534 | -961 | -183 |
| Other Working Capital | -1,619 | -178 | -1,632 | -1,181 | -1,306 |
| Other Operating Activity | 1,925 | 3,714 | 3,669 | 2,278 | 5,915 |
| Operating Cash Flow | $-4,454 | $-26,127 | $-19,946 | $-13,567 | $-7,739 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -11,463 | -11,463 | -8,337 | N/A |
| Sale Of Investment | N/A | 11,675 | 4,500 | N/A | N/A |
| Investing Cash Flow | $N/A | $212 | $-6,963 | $-8,337 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 118 | 94 | 94 | 5 |
| Other Financing Activity | 3,856 | 17,874 | 16,913 | 16,913 | 0 |
| Financing Cash Flow | $3,856 | $17,992 | $17,007 | $17,007 | $5 |
| Exchange Rate Effect | 51 | 135 | 75 | 48 | 72 |
| Beginning Cash Position | 5,066 | 12,854 | 12,854 | 12,854 | 12,854 |
| End Cash Position | 4,519 | 5,066 | 3,027 | 8,005 | 5,192 |
| Net Cash Flow | $-547 | $-7,788 | $-9,827 | $-4,849 | $-7,662 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,454 | -26,127 | -19,946 | -13,567 | -7,739 |
| Free Cash Flow | -4,454 | -26,127 | -19,946 | -13,567 | -7,739 |